The Adequacy of Phosphorus Binder Prescriptions among American Hemodialysis Patients

@article{Huml2012TheAO,
  title={The Adequacy of Phosphorus Binder Prescriptions among American Hemodialysis Patients},
  author={Anne M. Huml and Catherine M. Sullivan and Janeen B. Leon and Ashwini R. Sehgal},
  journal={Renal Failure},
  year={2012},
  volume={34},
  pages={1258 - 1263}
}
Because hemodialysis treatment has a limited ability to remove phosphorus, dialysis patients must restrict dietary phosphorus intake and use phosphorus binding medication. Among patients with restricted dietary phosphorus intake (1000 mg/d), phosphorus binders must bind about 250 mg of excess phosphorus per day and among patients with more typical phosphorus intake (1500 mg/d), binders must bind about 750 mg/d. To determine the phosphorus binding capacity of binder prescriptions among American… Expand
Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy
Introduction: Phosphate balance could be reached only by an optimized combination of dietary restriction and the careful use of phosphate binders for patients receiving standard hemodialysisExpand
Sucroferric Oxyhydroxide as Part of Combination Phosphate Binder Therapy among Hemodialysis Patients
TLDR
For patients on hemodialysis with uncontrolled hyperphosphatemia, combination therapy with SO may allow for sustained improvements in sP control without adversely affecting phosphate binder pill burden. Expand
Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials
TLDR
Compared with standard therapy, LC reduced all-cause mortality in patients on hemodialysis but did not decrease the risk of cardiovascular events. Expand
Efficacy and safety of PT20, an iron-based phosphate binder, for the treatment of hyperphosphataemia: a randomized, double-blind, placebo-controlled, dose-ranging, Phase IIb study in patients with haemodialysis-dependent chronic kidney disease
  • M. Sampson, Nuno Faria, J. Powell
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2020
TLDR
In this first study investigating the efficacy and safety of PT20 in patients with hyperphosphataemia and dialysis-dependent CKD, PT20 significantly lowered serum phosphate concentrations and was generally well tolerated. Expand
Phosphate control in end-stage renal disease: barriers and opportunities.
TLDR
Common challenges in meeting clinical targets for serum phosphorus levels in the dialysis population are summarized and potential opportunities for improvement are identified. Expand
The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.
  • J. Leon, C. Sullivan, A. Sehgal
  • Medicine
  • Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
  • 2013
TLDR
Phosphorus additives are common in best-selling processed groceries and contribute significantly to their phosphorus content, and phosphorus additive foods are less costly than phosphorus additive-free foods. Expand
Risk of Band Keratopathy in Patients with End-Stage Renal Disease
TLDR
ESRD increases the risk of band keratopathy and close interdisciplinary collaboration between nephrologists and ophthalmologists is important to deal with band ker atopathy following ESRD and prevent visual acuity impairments. Expand
Avaliação do consumo alimentar de pacientes com doença renal crônica em hemodiálise
TLDR
O consumo alimentar dos pacientes apresentou-se inadequado, ressaltando a necessidade de realizacao de medidas de educacao nutricional para that a ingestao dos mesmos se adeque as recomendacoes e as comorbidades decorrentes do consumo inadequado sejam evitadas. Expand
Daily dietary phosphorus intake variability and patient adherence to phosphate-binder therapy in hemodialysis patients
  • 2019

References

SHOWING 1-10 OF 49 REFERENCES
The absorption of dietary phosphorus and calcium in hemodialysis patients.
TLDR
The absorption of dietary phosphorus is influenced only modestly by 1,25(OH)2-D3 and is inhibited to an equal but only modest degree by various aluminum antacids and by calcium carbonate. Expand
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphorus Balance with Daily Dialysis
TLDR
The definition of adequacy of dialysis should be re‐evaluated and consideration given to alternative markers, and the elimination kinetics of phosphorus as they relate to these alternative daily dialysis schedules and the clinical implications of overall phosphorus balance are discussed here. Expand
The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial.
  • M. Schorr, B. Manns, +7 authors B. Hemmelgarn
  • Medicine
  • Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
  • 2011
TLDR
As compared with conventional dialysis, NHD was associated with a nonstatistically significant increase in dietary intake for some nutrients, with maintenance of serum levels for potassium, calcium, and phosphorus. Expand
Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
TLDR
Investigating the effect of limiting the intake of phosphorus-containing food additives on serum phosphorus levels among patients with end-stage renal disease resulted in modest improvements in hyperphosphatemia. Expand
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphorus Homeostasis in Normal Health and in Chronic Kidney Disease Patients with Special Emphasis on Dietary Phosphorus Intake
TLDR
Despite all the oral phosphorus binders currently available in the market, dietary restriction of this mineral remains a cornerstone for the prevention and treatment of hyperphosphatemia. Expand
Results of a pilot program to improve phosphorus outcomes in hemodialysis patients.
  • T. Mayne, D. Benner, +6 authors M. Krishnan
  • Medicine
  • Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
  • 2012
TLDR
These results show proof-of-concept that a focused phosphorus management program targeting both staff members and patients can significantly improve patient outcomes without compromising nutritional status. Expand
Hidden Sources of Phosphorus in the Typical American Diet: Does it Matter in Nephrology?
TLDR
An understanding of the phosphorus content of the current American diet is conveyed to better equip nephrologists in their attempt to control hyperphosphatemia. Expand
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study.
  • R. Wald, M. Sarnak, +4 authors D. Miskulin
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2008
TLDR
Cumulative time-dependent analyses provide a different framework for analyzing the impact of factors that may mediate adverse events in hemodialysis patients and support maintaining serum phosphorus levels atLess than 6 mg/dL, calcium levels at less than 11 mg/DL, and Ca x P product at less Than 50 mg(2)/dL(2). Expand
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
TLDR
This study concludes that a large percentage of hemodialysis patients who have a serum phosphorus level above 6.5 mg/dL and that this places them at increased risk of death, and supports the need for vigorous control of hyperphosphatemia to improve patient survival. Expand
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
  • E. Young, T. Akiba, +4 authors M. Jadoul
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 2004
TLDR
The DOPPS provides a useful comparison benchmark for the state of mineral metabolism management of patients with kidney disease and affirms the association between mineral metabolism and important patient outcomes. Expand
...
1
2
3
4
5
...